Education
About Us
Working with TipRanks
Follow Us
Senores Pharmaceuticals Ltd. (IN:SENORES)
:SENORES
Total Valuation
Senores Pharmaceuticals Ltd. has a market cap or net worth of ₹35.94B. The enterprise value is ₹22.60B.
Market Cap₹35.94B
Enterprise Value₹22.60B
Share Statistics
Senores Pharmaceuticals Ltd. has 46,053,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,053,590
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Senores Pharmaceuticals Ltd.’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 11.50%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)11.50%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee19.73M
Profits Per Employee3.64M
Employee Count194
Asset Turnover26.28
Inventory Turnover0.06
Valuation Ratios
The current PE Ratio of Senores Pharmaceuticals Ltd. is 34.9. Senores Pharmaceuticals Ltd.’s PEG ratio is 0.00.
PE Ratio34.9
PS Ratio5.36
PB Ratio2.61
Price to Fair Value2.61
Price to FCF-10.08
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, Senores Pharmaceuticals Ltd. had revenue of 3.83B and earned 6.85M in profits. Earnings per share was 0.19.
Revenue3.83B
Gross Profit14.11M
Operating Income728.10M
Pretax Income705.70M
Net Income6.85M
EBITDA1.08B
Earnings Per Share (EPS)0.19
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Senores Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.10
52-Week Price Change36.01%
50-Day Moving Average811.09
200-Day Moving Average705.43
Relative Strength Index (RSI)39.47
Average Volume (3m)11.47K
Important Dates
Senores Pharmaceuticals Ltd. upcoming earnings date is May 14, 2026, Before Open (Confirmed).
Last Earnings DateJan 20, 2026
Next Earnings DateMay 14, 2026
Ex-Dividend Date―
Financial Position
Senores Pharmaceuticals Ltd. as a current ratio of 3.00, with Debt / Equity ratio of ―
Current Ratio3.00
Quick Ratio2.77
Debt to Market Cap0.15
Net Debt to EBITDA1.94
Interest Coverage Ratio3.57
Taxes
In the past 12 months, Senores Pharmaceuticals Ltd. has paid 1.43M in taxes.
Income Tax1.43M
Effective Tax Rate<0.01
Enterprise Valuation
Senores Pharmaceuticals Ltd. EV to EBITDA ratio is 20.97, with an EV/FCF ratio of -11.11.
EV to Sales5.90
EV to EBITDA20.97
EV to Free Cash Flow-11.11
EV to Operating Cash Flow-49.22
Balance Sheet
Senores Pharmaceuticals Ltd. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share-₹58.10
Margins
Gross margin is ―, with operating margin of 19.02%, and net profit margin of 0.18%.
Gross Margin―
Operating Margin19.02%
Pretax Margin18.44%
Net Profit Margin0.18%
EBITDA Margin28.16%
EBIT Margin23.76%
Analyst Forecast
The average price target for Senores Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―